Robert Beauchamp
Principal Investigator
Last active: 10/31/2018

Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells.

Fujimoto K, Hosotani R, Miyamoto Y, Doi R, Koshiba T, Otaka A, Fujii N, Beauchamp RD, Imamura M
Cancer Lett. 2000 159 (2): 151-8

PMID: 10996726

In this study, we examined whether or not a small peptide derived from p16(INK4A) protein with the antennapedia carrier sequence could inhibit the growth of pancreatic cancer cells through the inhibition of cell cycle progression. Growth inhibition by the p16-derived peptide was observed in a time- and dose-dependent manner in AsPC-1 and BxPC-3 cells (p16-negative and pRb-positive), whereas Saos-2 cells (p16-positive and pRb-negative) showed no inhibitory effect. In AsPC-1 and BxPC-3 cells, the proportion of cells in the G(1) phase markedly increased 48 h after treatment with 20 microM p16-derived peptide. Cell-cycle analysis of Saos-2 cells showed little change during the entire period of treatment. Immunoblot analysis showed inhibition of pRb phosphorylation after treatment of BxPC-3 with 10 microM p16 peptide. Furthermore, the p16 peptide caused a decrease in cyclin A at later times of treatment. These results demonstrate that the p16-derived peptide can inhibit the growth of p16-negative and pRb-positive pancreatic cancer cells by means of G(1) phase cell cycle arrest resulting from the inhibition of pRb phosphorylation. Restoration of p16/pRb tumor-suppressive pathway by re-expression of p16(INK4A) may play a therapeutic role in the treatment of pancreatic cancer.

MeSH Terms (19)

Amino Acid Sequence Antennapedia Homeodomain Protein Biotinylation Carrier Proteins Cell Cycle Cell Division Cyclin-Dependent Kinase Inhibitor p16 Cyclin A Dose-Response Relationship, Drug Homeodomain Proteins Humans Molecular Sequence Data Nuclear Proteins Pancreatic Neoplasms Phosphorylation Recombinant Fusion Proteins Retinoblastoma Protein Transcription Factors Tumor Cells, Cultured

Connections (2)

This publication is referenced by other Labnodes entities:

Links